Total Payments
$526.25
2023 Payments
$77.08
Companies
17
Transactions
27
Medicare Patients
17,573
Medicare Billing
$627,934
Payment Breakdown by Category
Food & Beverage$508.46 (96.6%)
Education$17.79 (3.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $508.46 | 26 | 96.6% |
| Education | $17.79 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $92.41 | 2 | $0 (2023) |
| Incyte Corporation | $45.65 | 3 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $45.11 | 2 | $0 (2017) |
| EISAI INC. | $39.07 | 2 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $38.58 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $38.56 | 3 | $0 (2019) |
| Millennium Pharmaceuticals, Inc. | $34.57 | 1 | $0 (2017) |
| Puma Biotechnology, Inc. | $33.75 | 2 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $23.51 | 2 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $20.24 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $77.08 | 1 | Boston Scientific Corporation ($77.08) |
| 2022 | $15.33 | 1 | Boston Scientific Corporation ($15.33) |
| 2020 | $15.24 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($15.24) |
| 2019 | $182.55 | 11 | Puma Biotechnology, Inc. ($33.75) |
| 2018 | $85.45 | 5 | Seattle Genetics, Inc. ($19.93) |
| 2017 | $150.60 | 8 | E.R. Squibb & Sons, L.L.C. ($45.11) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/21/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $77.08 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/04/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: General - Pain Management_NMD | ||||||
| 01/22/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Oncology | ||||||
| 12/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $19.26 | General |
| 11/21/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Oncology | ||||||
| 10/24/2019 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug) | Education | In-kind items and services | $17.79 | General |
| Category: PARENTERAL IRON REPLACEMENT | ||||||
| 09/05/2019 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $17.84 | General |
| Category: Hematology/Oncology | ||||||
| 07/10/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Oncology | ||||||
| 05/16/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Oncology | ||||||
| 04/12/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $12.14 | General |
| Category: Hematology/Oncology | ||||||
| 04/03/2019 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Immunology | ||||||
| 01/09/2019 | EISAI INC. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: Oncology | ||||||
| 01/04/2019 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Oncology | ||||||
| 11/01/2018 | GENZYME CORPORATION | GAUCHER-DISEASE (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| 10/25/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Oncology | ||||||
| 05/31/2018 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.67 | General |
| Category: Hematology/Oncology | ||||||
| 04/05/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Oncology | ||||||
| 12/21/2017 | Millennium Pharmaceuticals, Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: Oncology | ||||||
| 11/28/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Oncology | ||||||
| 11/14/2017 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $22.58 | General |
| Category: Oncology | ||||||
| 09/29/2017 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Oncology | ||||||
| 06/01/2017 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug), ALOXI | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: ONCOLOGY | ||||||
| 05/11/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,826 | 3,861 | $643,333 | $132,195 |
| 2022 | 25 | 4,437 | 4,684 | $774,300 | $165,430 |
| 2021 | 33 | 5,114 | 5,600 | $842,326 | $182,986 |
| 2020 | 40 | 4,196 | 4,753 | $684,627 | $147,324 |
Total Patients
17,573
Total Services
18,898
Medicare Billing
$627,934
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 712 | 712 | $176,068 | $41,961 | 23.8% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 710 | 710 | $107,480 | $25,517 | 23.7% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2023 | 204 | 204 | $91,689 | $11,661 | 12.7% |
| 77067 | Screening mammography | Facility | 2023 | 268 | 268 | $42,612 | $10,329 | 24.2% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 268 | 268 | $34,840 | $8,228 | 23.6% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 119 | 132 | $26,496 | $4,664 | 17.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 424 | 424 | $18,400 | $4,489 | 24.4% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 140 | 145 | $16,835 | $3,591 | 21.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 272 | 272 | $11,152 | $2,717 | 24.4% |
| 76641 | Complete ultrasound scan of 1 breast | Facility | 2023 | 77 | 77 | $24,168 | $2,585 | 10.7% |
| 77066 | Diagnostic mammography of both breasts | Office | 2023 | 59 | 60 | $14,953 | $2,410 | 16.1% |
| 19081 | Biopsy of breast and placement of locating device using x-ray with needle, first growth | Office | 2023 | 15 | 15 | $14,300 | $2,376 | 16.6% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 79 | 80 | $14,013 | $2,355 | 16.8% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Office | 2023 | 13 | 13 | $12,024 | $1,924 | 16.0% |
| 19285 | Placement of locating device in breast using ultrasound guidance, first growth | Office | 2023 | 12 | 12 | $4,572 | $750.01 | 16.4% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 19 | 19 | $3,971 | $719.10 | 18.1% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 28 | 30 | $3,135 | $709.10 | 22.6% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 94 | 99 | $3,960 | $698.42 | 17.6% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 19 | 22 | $3,696 | $654.57 | 17.7% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 75 | 75 | $3,525 | $619.50 | 17.6% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 30 | 30 | $2,278 | $544.68 | 23.9% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 18 | 18 | $2,812 | $512.44 | 18.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2023 | 13 | 13 | $2,405 | $370.79 | 15.4% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2023 | 33 | 33 | $1,322 | $366.21 | 27.7% |
| 76098 | X-ray of surgical specimen | Facility | 2023 | 26 | 28 | $1,652 | $360.08 | 21.8% |
About Dr. Anna Mah, M.D
Dr. Anna Mah, M.D is a Diagnostic Radiology healthcare provider based in Danbury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932194438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Mah, M.D has received a total of $526.25 in payments from pharmaceutical and medical device companies, with $77.08 received in 2023. These payments were reported across 27 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($508.46).
As a Medicare-enrolled provider, Mah has provided services to 17,573 Medicare beneficiaries, totaling 18,898 services with total Medicare billing of $627,934. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Danbury, CT
- Active Since 09/12/2005
- Last Updated 09/07/2023
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1932194438
Products in Payments
- NINLARO (Drug) $53.89
- JAKAFI (Drug) $45.65
- Halaven (Drug) $39.07
- Nerlynx (Drug) $33.75
- VYXEOS (Drug) $23.51
- EMPLICITI (Biological) $22.58
- OPDIVO (Biological) $22.53
- ULTOMIRIS (Drug) $20.24
- ADCETRIS (Biological) $19.93
- ZEJULA (Drug) $18.16
- FERAHEME (Drug) $17.79
- Rubraca (Drug) $17.61
- General - Pain Management (Device) $15.33
- CALQUENCE (Drug) $15.29
- Xofigo (Drug) $15.24
- AKYNZEO (Drug) $13.15
- GAUCHER-DISEASE (Drug) $12.92
- FASLODEX (Drug) $11.96
- TAGRISSO (Drug) $11.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Danbury
Eric Reiner, Do, DO
Diagnostic Radiology — Payments: $323,442
Diagnostic Radiology $323,442
Dr. Barbara Blanco, M.d, M.D
Diagnostic Radiology — Payments: $18,395
Diagnostic Radiology $18,395
Mr. Todd Everett, Md, MD
Diagnostic Radiology — Payments: $874.09
Diagnostic Radiology $874.09
Michael Hollander, Md, MD
Diagnostic Radiology — Payments: $530.17
Diagnostic Radiology $530.17
Dr. Fatejeet Sandhu, M.d, M.D
Diagnostic Radiology — Payments: $307.66
Diagnostic Radiology $307.66
Dr. Allison Rubin, M.d, M.D
Diagnostic Radiology — Payments: $292.42
Diagnostic Radiology $292.42